Guide to using AAV vectors in gene therapy
Drug Discovery World
FEBRUARY 8, 2024
AAV is optimal for gene therapy due to its efficiency and safety in humans; however, AAV processes can present obstacles for researchers. These include automated solutions, proprietary genomics protocols, specialists to advise on global cGMP repository and logistics, plus experts to guide researchers through advanced therapy development.
Let's personalize your content